Pulmonary Involvement

  • Clio P. Mavragani
  • George E. Tzelepis
  • Haralampos M. Moutsopoulos


Isolated cases of lung involvement in Sjögren’s syndrome (SS) were first reported in the early 60s [1]. Since then an extensive number of reports have attempted to characterize lung involvement, often with conflicting data. Principally interstitial [2–5] to mixed [6, 7] or purely obstructive respiratory patterns [8] have been described, with frequencies that range from 9% to 75% [3, 4].


Interstitial Lung Disease Sodium Cromoglycate Cryptogenic Organize Pneumonia Minor Salivary Gland Biopsy Lymphocytic Interstitial Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bucher U, Hadorn W. Chronic bronchitis: the significance of sputum examination for diagnosis and therapy. Med Klin. 1960;55:688–92.PubMedGoogle Scholar
  2. 2.
    Fairfax AJ, Haslam PL, Pavia D, Sheahan NF, Bateman JR, Agnew JE, et al. Pulmonary disorders associated with Sjögren’s syndrome. Q J Med. 1981;50:279–95.PubMedGoogle Scholar
  3. 3.
    Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjögren’s syndrome. A clinical, functional, and histologic study. Chest. 1985;88:226–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Strimlan CV, Rosenow 3rd EC, Divertie MB, Harrison Jr EG. Pulmonary manifestations of Sjögren’s syndrome. Chest. 1976;70:354–61.PubMedCrossRefGoogle Scholar
  5. 5.
    Oxholm P. Primary Sjögren’s syndrome–clinical and laboratory markers of disease activity. Semin Arthritis Rheum. 1992;22:114–26.PubMedCrossRefGoogle Scholar
  6. 6.
    Vitali C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S. Lung involvement in Sjögren’s syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis. 1985;44:455–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Segal I, Fink G, Machtey I, Gura V, Spitzer SA. Pulmonary function abnormalities in Sjögren’s syndrome and the sicca complex. Thorax. 1981;36:286–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Newball HH, Brahim SA. Chronic obstructive airway disease in patients with Sjögren’s syndrome. Am Rev Respir Dis. 1977;115:295–304.PubMedGoogle Scholar
  9. 9.
    Watanabe M, Naniwa T, Hara M, Arakawa T. Maeda T. Pulmonary manifestations in Sjögren’s syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol. 2010;37:365–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Papiris SA, Tsonis IA, Moutsopoulos HM. Sjögren’s syndrome. Semin Respir Crit Care Med. 2007;28:459–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Vitali C, Viegi G, Tassoni S, Tavoni A, Paoletti P, Bibolotti E, et al. Lung function abnormalities in different connective tissue diseases. Clin Rheumatol. 1986;5:181–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187–231.CrossRefGoogle Scholar
  13. 13.
    Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58:61–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Bariffi F, Pesci A, Bertorelli G, Manganelli P, Ambanelli U. Pulmonary involvement in Sjögren’s syndrome. Respiration. 1984;46:82–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, et al. Pleuropulmonary abnormalities in primary Sjögren’s syndrome. J Rheumatol. 1993;20:831–7.PubMedGoogle Scholar
  16. 16.
    Koyama M, Johkoh T, Honda O, Mihara N, Kozuka T, Tomiyama N, et al. Pulmonary involvement in primary Sjögren’s syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 2001;16:290–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Robinson DA, Meyer CF. Primary Sjögren’s syndrome associated with recurrent sinopulmonary infections and bronchiectasis. J Allergy Clin Immunol. 1994;94:263–4.PubMedGoogle Scholar
  18. 18.
    Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjögren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol. 1997;169:655–8.PubMedGoogle Scholar
  19. 19.
    Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16:282–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Salaffi F, Manganelli P, Carotti M, Baldelli S, Blasetti P, Subiaco S, et al. A longitudinal study of pulmonary involvement in primary Sjögren’s syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol. 1998;37:263–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Papiris SA, Saetta M, Turato G, La Corte R, Trevisani L, Mapp CE, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren’s syndrome. Am J Respir Crit Care Med. 1997;156:637–41.PubMedGoogle Scholar
  22. 22.
    Andoh Y, Shimura S, Sawai T, Sasaki H, Takishima T, Shirato K. Morphometric analysis of airways in Sjögren’s syndrome. Am Rev Respir Dis. 1993;148:1358–62.PubMedGoogle Scholar
  23. 23.
    Taouli B, Brauner MW, Mourey I, Lemouchi D, Grenier PA. Thin-section chest CT findings of primary Sjögren’s syndrome: correlation with pulmonary function. Eur Radiol. 2002;12:1504–11.PubMedCrossRefGoogle Scholar
  24. 24.
    Franquet T, Diaz C, Domingo P, Gimenez A, Geli C. Air trapping in primary Sjögren syndrome: correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr. 1999;23:169–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R. Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 1991;50:36–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Ludviksdottir D, Janson C, Hogman M, Gudbjornsson B, Bjornsson E, Valtysdottir S, et al. Increased nitric oxide in expired air in patients with Sjögren’s syndrome. BHR study group. Bronchial hyperresponsiveness. Eur Respir J. 1999;13:739–43.PubMedCrossRefGoogle Scholar
  27. 27.
    Stalenheim G, Gudbjornsson B. Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in Sjögren’s syndrome. Allergy. 1997;52:423–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J. 2008;31:11–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004;25:549–59, vii.PubMedCrossRefGoogle Scholar
  30. 30.
    Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H, et al. Minor salivary gland biopsy to detect primary Sjögren syndrome in patients with interstitial lung disease. Chest. 2009;136:1072–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM. Reappraisal of respiratory abnormalities in primary and secondary Sjögren’s syndrome. A controlled study. Chest. 1986;90:370–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, et al. Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? Rheumatol Int. 2010;30:1317–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren’s syndrome. Chest. 1991;99:1394–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, et al. Pulmonary manifestations of Sjögren’s syndrome. Respiration. 2009;78:377–86.PubMedCrossRefGoogle Scholar
  35. 35.
    Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjögren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171:632–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006;130:1489–95.PubMedCrossRefGoogle Scholar
  37. 37.
    Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjögren’s syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med. 1996;154:794–9.PubMedGoogle Scholar
  38. 38.
    American Thoracic Society; European Respiratory Society International. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2001;165:277–304.Google Scholar
  39. 39.
    Travis WD, Hunninghake G, King Jr TE, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177:1338–47.PubMedCrossRefGoogle Scholar
  40. 40.
    Yamadori I, Fujita J, Bandoh S, Tokuda M, Tanimoto Y, Kataoka M, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren’s syndrome. Rheumatol Int. 2002;22:89–92.PubMedCrossRefGoogle Scholar
  41. 41.
    Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K. Sjögren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest. 1988;94:438–40.PubMedCrossRefGoogle Scholar
  42. 42.
    Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16:700–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973;57:809–43.PubMedGoogle Scholar
  44. 44.
    Parke AL. Pulmonary manifestations of primary Sjögren’s syndrome. Rheum Dis Clin North Am. 2008;34:907–20, viii.PubMedCrossRefGoogle Scholar
  45. 45.
    Ioannou S, Toya SP, Tomos P, Tzelepis GE. Cryptogenic organizing pneumonia associated with primary Sjögren’s syndrome. Rheumatol Int. 2008;28:1053–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Cordier JF. Update on cryptogenic organising pneumonia (idiopathic bronchiolitis obliterans organising pneumonia). Swiss Med Wkly. 2002;132:588–91.PubMedGoogle Scholar
  47. 47.
    Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med. 1993;14:611–22.PubMedGoogle Scholar
  48. 48.
    Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging. 2009;24:299–309.PubMedCrossRefGoogle Scholar
  49. 49.
    Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K. Pulmonary lesions associated with Sjögren’s syndrome: radiographic and CT findings. Br J Radiol. 2003;76:880–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Sakamoto O, Saita N, Ando M, Kohrogi H, Suga M, Ando M. Two cases of Sjögren’s syndrome with multiple bullae. Intern Med. 2002;41:124–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Hubscher O, Re R, Iotti R. Cystic lung disease in Sjögren’s syndrome. J Rheumatol. 2002;29:2235–6.PubMedGoogle Scholar
  52. 52.
    Schlegel J, Kienast K, Storkel S, Ferlinz R. Primary pulmonary nodular amyloidosis and multiple emphysematous bullae in Sjögren syndrome. Pneumologie. 1992;46:634–7.PubMedGoogle Scholar
  53. 53.
    Bonner Jr H, Ennis RS, Geelhoed GW, Tarpley Jr TM. Lymphoid infiltration and amyloidosis of lung in Sjögren’s syndrome. Arch Pathol. 1973;95:42–4.PubMedGoogle Scholar
  54. 54.
    Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren’s syndrome: a cross sectional and longitudinal study. Thorax. 1991;46:180–3.PubMedCrossRefGoogle Scholar
  55. 55.
    Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2000;59:709–12.PubMedCrossRefGoogle Scholar
  56. 56.
    Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren’s syndrome. Nat Clin Pract Rheumatol. 2006;2:252–61.PubMedCrossRefGoogle Scholar
  57. 57.
    Ogasawara H, Sekiya M, Murashima A, Hishikawa T, Tokano Y, Sekigawa I, et al. Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjögren’s syndrome. Clin Rheumatol. 1998;17:160–2.PubMedCrossRefGoogle Scholar
  58. 58.
    Schnabel A, Reuter M, Gross WL. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum. 1998;41:1215–20.PubMedCrossRefGoogle Scholar
  59. 59.
    Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, et al. High-resolution CT imaging of the lung for patients with primary Sjögren’s syndrome. Eur J Radiol. 2004;52:137–43.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Clio P. Mavragani
    • 1
  • George E. Tzelepis
    • 2
  • Haralampos M. Moutsopoulos
    • 2
  1. 1.Department of Experimental Physiology, School of MedicineUniversity of AthensAthensGreece
  2. 2.Department of Pathophysiology, School of MedicineUniversity of AthensAthensGreece

Personalised recommendations